Abstract
The Melbourne high school Tay–Sachs disease (TSD) carrier screening program began in 1997. The aim of this study was to assess the outcomes of this screening program among those who had testing more than 5 years ago, to evaluate the long-term impact of screening. A questionnaire was used for data collection and consisted of validated scales and purposively designed questions. Questionnaires were sent to all carriers and two non-carriers for each carrier who were screened in the program between 1999 and 2005. Twenty-four out of 69 (34.8 %) carriers and 30/138 (21.7 %) non-carriers completed the questionnaire. Most participants (82 %) retained good knowledge of TSD and there was no evidence of a difference in knowledge between carriers and non-carriers. Most participants (83 %) were happy with the timing and setting of screening and thought that education and screening for TSD should be offered during high school. There was no difference between carriers and non-carriers in mean scores for the State Trait Anxiety Inventory and Decision Regret Scale. This evaluation indicated that 5–11 years post high school screening, those who were screened are supportive of the program and that negative consequences are rare.
Similar content being viewed by others
References
Ayme S, Bobrow M, Coviello D, Evers-Kiebooms G, Farndon P, Kaariainen H, Tranebjaerg L (2000) Population genetic screening programmes: proposed recommendations of the European Society of Human Genetics. Eur J Hum Genet 8:998–1000
Bach G, Tomczak J, Risch N, Ekstein J (2001) Tay–Sachs screening in the Jewish Ashkenazi population: DNA testing is the preferred procedure. Am J Med Genet 99:70–75
Barlow-Stewart K, Brunett L, Proos A, Howell V, Huq F, Lazarus R, Aizenberg H (2003) A genetic screening programme for Tay–Sachs disease and cystic fibrosis for Australian Jewish high school students. J Med Genet 40:e45
Brehaut JC, O'Connor AM, Wood TJ, Hack TF, Siminoff L, Gordon E, Feldman-Stewart D (2003) Validation of a decision regret scale. Med Decis Making 23:281–292
Childs B, Gordis L, Kaback M, Kazazian HH (1976) Tay–Sachs screening—motives for participating and knowledge of genetics and probability. Am J Hum Genet 28:537–549
Clow CL, Scriver CR (1977) Knowledge about and attitudes toward genetic screening among high school students—Tay–Sachs experience. Pediatr 59:86–91
Delatycki MB (2008) Population screening for reproductive risk for single gene disorders in Australia: now and the future. Twin Res Hum Genet 11:422–430
Desnick RJ, Kaback MM (2001) Future perspectives for Tay–Sachs disease. Adv Genet 44:349–356
Frumkin A, Zlotogora J (2008) Genetic screening for reproductive purposes at school: is it a good strategy? Am J Med Genet A 146A:264–269
Gason AA, Sheffield E, Bankier A, Aiken MA, Metcalfe S, Stewart KB, Delatycki MB (2003) Evaluation of a Tay–Sachs disease screening program. Clin Genet 63:386–392
Horowitz M, Wilner N, Alvarez W (1979) Impact of Event Scale—measure of subjective stress. Psychosom Med 41:209–218
Ioannou L, Massie J, Lewis S, Petrou V, Gason A, Metcalfe S, Delatycki MB (2010) Evaluation of a multi-disease carrier screening programme in Ashkenazi Jewish high schools. Clin Genet 78:21–31
Kaback MM (2000) Population-based genetic screening for reproductive counseling: the Tay–Sachs disease model. Eur J Pediatr 159:S192–S195
Kaback MM, Zeiger RS, Reynolds LW, Sonnebor M (1974) Approaches to control and prevention of Tay–Sachs disease. Prog Med Genet 10:103–134
Marteau T, Bekker H (1992) The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 31:301–306
Marteau TM, Vanduijn M, Ellis I (1992) Effects of genetic screening on perceptions of health—a pilot study. J Med Genet 29:24–26
Michie S, McDonald V, Bobrow M, McKeown C, Marteau T (1996) Parents' responses to predictive genetic testing in their children: report of a single case study. J Med Genetics 33:313–318
Mitchell JJ, Capua A, Clow CL, Scriver CR (1996) Twenty-year outcome analysis of genetic screening programs for Tay–Sachs and beta-thalassemia disease carriers in high schools. Am J Hum Genet 59:793–798
Ross LF (2006) Heterozygote carrier testing in high schools abroad: what are the lessons for the US? J Law Med Ethics 34:753–764
Resta R, Biesecker B, Bennett R, Blum S, Hahn S, Strecker M, Williams J (2006) A new definition of genetic counseling: National Society of Genetic Counselors' Task Force report. J Genet Couns 15:77–88
Smith CO, Lipe HP, Bird TD (2004) Impact of presymptomatic genetic testing for hereditary ataxia and neuromuscular disorders. Arch Neurol 61:875–880
Zeesman S, Clow CL, Cartier L, Scriver CR (1984) A private view of heterozygosity—8-year follow-up-study on carriers of the Tay–Sachs gene detected by high-school screening in Montreal. Am J Med Genet 18:769–778
Acknowledgments
The authors thank the participants for completing the questionnaire. We thank the teachers and coordinators at the schools in which the program runs, and the Pratt Foundation for supporting the program.
Conflict of interest
MBD is a NHMRC Practitioner Fellow; SL is funded by a NHMRC Capacity Building Grant. There is no conflict of interest for any of the authors on this paper.
Ethics committee approval
This study was approved by the Royal Children's Hospital Human Research Ethics Committee (CA29176) and thus complies with the requirements for research conduct in Australia.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Curd, H., Lewis, S., Macciocca, I. et al. High school Tay–Sachs disease carrier screening: 5 to 11-year follow-up. J Community Genet 5, 139–146 (2014). https://doi.org/10.1007/s12687-013-0163-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-013-0163-z